47 results on '"Asakura J"'
Search Results
2. The epidemiology of sepsis in paediatric intensive care units in Brazil (the Sepsis PREvalence Assessment Database in Pediatric population, SPREAD PED): an observational study
- Author
-
de Souza, Daniela Carla, primary, Gonçalves Martin, Joelma, additional, Soares Lanziotti, Vanessa, additional, de Oliveira, Cláudio Flauzino, additional, Tonial, Cristian, additional, de Carvalho, Werther Brunow, additional, Roberto Fioretto, José, additional, Pedro Piva, Jefferson, additional, Juan Troster, Eduardo, additional, Siqueira Bossa, Aline, additional, Gregorini, Flávia, additional, Ferreira, Josiane, additional, Lubarino, Juliana, additional, Biasi Cavalcanti, Alexandre, additional, Ribeiro Machado, Flávia, additional, Silva, SC, additional, Giacomazzi, J, additional, Boldrini, Domingos A., additional, Gilli, FH, additional, Castro, LC de, additional, Albuquerque, ML de, additional, Osorio, VCTG, additional, Elias, MLC, additional, Câmara, AA da, additional, Maia, M, additional, Carvalho, PB de, additional, Augusto, FM, additional, Figueiredo, RCCM de, additional, Ikino, EL, additional, Nogueres, FAS, additional, Almeida, RJ de, additional, Torreão, L, additional, Ramalho, J, additional, Camões, MMS, additional, Oliveira, CS de, additional, Serafim, VIIS, additional, Junior, J Colleti, additional, Almeida, CG de, additional, Costa, MHM da, additional, Valerio, JF, additional, Navajas, ME, additional, Riveiro, PM, additional, Lubiana, A, additional, Brito, ACLC, additional, Moretto, V, additional, Rachid, LMMD, additional, Valle, M, additional, Souza, PP de, additional, Victor, RPL, additional, Castro, NR, additional, Sakomura, T, additional, Molon, M, additional, Ferreira, AR, additional, Fonseca, JG da, additional, Cunali, VCA, additional, Chagas, VCA, additional, Belek, G, additional, Rocha, TS da, additional, Mello, LCFF de, additional, Machado, LM, additional, Moliterno, NV, additional, Duran, C, additional, Sanos, CLEB, additional, Ribeiro, GT, additional, Silva, PSL da, additional, Lipinski, R, additional, Soledade, A, additional, Branco, KC, additional, Teles, ACO, additional, Cruz, GF da, additional, Mendonça, MR de, additional, Malheiros, E, additional, Vicari, J, additional, Izidro, PNT, additional, Campos, NMP, additional, Pontes, TC, additional, Carneiro, CRF, additional, Imamura, AH, additional, Yoshioka, FM, additional, Duarte, MCMB, additional, Menezes, T, additional, Falconiere, C, additional, Matos, F, additional, Zeitel, RS, additional, Nogueras, CC, additional, Silva, ML da, additional, Aprille, M, additional, Pires, TYM, additional, Portella, AF, additional, Flores, PVG, additional, Alfradique, PP, additional, Nascimento, RC, additional, Saldanha, MO, additional, Alves, AT, additional, Almeida, WJ de, additional, Rodrigues, M, additional, Lopes Júnior, E, additional, Komka, MRP, additional, Nascimento, MAR, additional, Lopes, CRC, additional, Bernardi, TMC, additional, Falcão, RV, additional, Fraga, AR, additional, Machado, AA, additional, Godoy, JEF, additional, Barcellos, J, additional, Queiroz, RLS, additional, Almeida, VVS de, additional, Lira, JZG, additional, Alvo, M, additional, Peçanha, TCP, additional, Sousa, AM de, additional, Sanches, CS, additional, Wendhausen, AR, additional, Pinheiro, SR, additional, Orione, MA, additional, Minossi, AM, additional, Bresolin, NL, additional, Martins, CDF, additional, Cury, VF, additional, Quinet, RPB, additional, Netto, AL, additional, Limonge, R, additional, Tamari, SST, additional, Souza, SER de, additional, Veiga, R, additional, Couto, NGCB, additional, Ribeiro, MFP, additional, Aguiar, AK de, additional, Evangelista, M, additional, Krauzer, JR, additional, Muller, H, additional, Genu, DHS, additional, Alvares, PA, additional, Maciel, KL, additional, Valente, FT, additional, Centeville, M, additional, Espinheira, GJ, additional, Silva, A da, additional, Vasconcelos, PL, additional, Hädrich, AZ, additional, Sousa, ALDGC, additional, Gandra, GA, additional, Souto, ACA, additional, Sabatini, L, additional, João, PRD, additional, Machado, ABMP, additional, Fonseca, FR, additional, Resende, APA, additional, Silva, RV da, additional, Silva, TP da, additional, Barros, LLT, additional, Souza, CSV de, additional, Harada, KO, additional, Calçado, D, additional, Pinheiro, LSB, additional, Frota, MCM, additional, Pulcheri, LB, additional, Silva, LM e, additional, Santos, KJ dos, additional, Nuncio, FH de, additional, Gomes Júnior, IO, additional, Gomes, ACC, additional, Klitzke, MA, additional, Souza, FR de, additional, Carvalho, FSC, additional, Lima, FP de, additional, Braun Filho, LR, additional, Oliveira, MAG de, additional, Castilho, T, additional, Pistelli, IP, additional, Paccez, JD, additional, Cendon, C, additional, Sapolnick, R, additional, Fronza, D, additional, Toscan, C, additional, Pinelli, RM, additional, Alencar, JV, additional, Pace, HL di, additional, Ramos, AD, additional, Molinari, AC, additional, Assis, JF, additional, Chavarri, APCR, additional, Pereira, RC, additional, Freitas, CL, additional, Salmen, ICDM, additional, Guerini, RCM, additional, Asakura, J, additional, Pires, ACR, additional, Benvenuti, G, additional, Fernandes, LM, additional, Oliveira, NF, additional, Barros, HJB, additional, Nascimento, LCE, additional, Machado, MB, additional, Santos, AOR dos, additional, Silva, AC da, additional, Oliveira, ACE de, additional, Reinheimer, SKY, additional, Mello, PCS, additional, Araújo, IO, additional, Rodrigues, KLC, additional, Amari, MN, additional, Andersson, M, additional, Petrini, LMCM, additional, Luz, AKSF, additional, Serafim, ESS, additional, Barbosa, RF, additional, Souza, D, additional, Delgado, AF, additional, Guerra, ALP, additional, Afiune, JY, additional, Huber, J, additional, Casonato, S, additional, Silva, DCB da, additional, Araujo, OR de, additional, Fialho, FMD, additional, Soares, LFR, additional, Queiroz Júnior, AA de, additional, Sartorelli, A, additional, Zuccoli, ACP, additional, Castelani, M, additional, Silva, LAA da, additional, Lima, SRA, additional, Araújo, MJSL de, additional, Cruz, ACS da, additional, Sillero, PM, additional, Sgorlon, G, additional, Alves, TRS, additional, Muniz, MMB, additional, Pereira, RHP, additional, Gonçalves, NR, additional, Teixeira, RPV, additional, Vasconcelos, IA, additional, Rossetti, CT, additional, Cesar, RG, additional, Alves, MAJ, additional, Martins, MK, additional, Rocha, JAR, additional, Arruda, L, additional, Grillo, ALY, additional, and Barros, G, additional
- Published
- 2021
- Full Text
- View/download PDF
3. Initial Flow Structure Control of Jet Diffusion Using a Coaxial DBD Plasma Actuator
- Author
-
Kimura, M., primary, Asakura, J., additional, Onishi, M., additional, Sayo, K., additional, and Miyagi, N., additional
- Published
- 2013
- Full Text
- View/download PDF
4. Formation process of InAs dots including Mn atoms and their physical properties
- Author
-
Okumura, S., primary, Asahi, H., additional, Zhou, Y. K., additional, Asakura, J., additional, Kanamura, M., additional, Asami, K., additional, Kubo, H., additional, Hamaguchi, C., additional, and Gonda, S., additional
- Published
- 2001
- Full Text
- View/download PDF
5. Growth and characterization of InMnAsSb for the sensor-memory device application at long wavelength region
- Author
-
Zhou, Y.K, Asahi, H, Okumura, S, Kanamura, M, Asakura, J, Asami, K, Nakajima, M, Harima, H, and Gonda, S
- Published
- 2001
- Full Text
- View/download PDF
6. InAs dots including Mn atoms fabricated by MOMBE
- Author
-
Zhou, Y.K, Asahi, H, Asakura, J, Okumura, S, Tashima, T, Sato, J, Asami, K, and Gonda, S
- Published
- 2000
- Full Text
- View/download PDF
7. Magnetic and optical properties of Mn-including InAs dots grown by metalorganic molecular beam epitaxy
- Author
-
Zhou, Y.K, Asahi, H, Asakura, J, Okumura, S, Asami, K, and Gonda, S
- Published
- 2000
- Full Text
- View/download PDF
8. Diabetes - experimental models
- Author
-
Blanco-Gozalo, V., primary, Blazquez-Medela, A., additional, Garcia-Sanchez, O., additional, Quiros, Y., additional, Montero, M., additional, Martinez-Salgado, C., additional, Lopez-Hernandez, F., additional, Lopez-Novoa, J., additional, Yao, L., additional, Qing, Z., additional, Hua, X., additional, Min, F., additional, Fei, M., additional, Ning, W., additional, Cantaluppi, V., additional, Figliolini, F., additional, Delena, M., additional, Beltramo, S., additional, Medica, D., additional, Tetta, C., additional, Segoloni, G., additional, Biancone, L., additional, Camussi, G., additional, Cunha, J. S., additional, Ferreira, V. M., additional, Naves, M. A., additional, Boim, M. A., additional, Zitman-Gal, T., additional, Golan, E., additional, Green, J., additional, Pasmanik-Chor, M., additional, Bernheim, J., additional, Benchetrit, S., additional, Riera, M., additional, Clotet, S., additional, Pascual, J., additional, Soler, M., additional, Nakai, K., additional, Fujii, H., additional, Kono, K., additional, Goto, S., additional, Hirata, M., additional, Shinohara, M., additional, Fukagawa, M., additional, Nishi, S., additional, Fan, Q., additional, Du, S., additional, Jiang, Y., additional, Wang, L., additional, Fang, L., additional, Radovits, T., additional, Mozes, M. M., additional, Rosivall, L., additional, Kokeny, G., additional, Aoki, R., additional, Tateoka, R., additional, Sekine, F., additional, Kikuchi, K., additional, Yamashita, Y., additional, Itoh, Y., additional, Cappuccino, L., additional, Garibotto, G., additional, D'Amato, E., additional, Villaggio, B., additional, Gianiorio, F., additional, Mij, M., additional, Viazzi, F., additional, Salvidio, G., additional, Verzola, D., additional, Piwkowska, A., additional, Rogacka, D., additional, Audzeyenka, I., additional, Kasztan, M., additional, Angielski, S., additional, Jankowski, M., additional, Gaber, E. W., additional, El-Attar, H. A., additional, Liu, J., additional, Zhang, W., additional, He, Y., additional, Macsai, E., additional, Takats, Z., additional, Derzbach, L., additional, Korner, A., additional, Vasarhelyi, B., additional, Huang, M. S., additional, Bo, H., additional, Liu, F., additional, Fu, P., additional, Tsotakos, N. E., additional, Tsilibary, E. C., additional, Drossopoulou, G. I., additional, Thawho, N., additional, Farid, N., additional, Peleg, A., additional, Levy, A., additional, Nakhoul, N., additional, Lenghel, A. R., additional, Borza, G., additional, Catoi, C., additional, Bondor, C. I., additional, Muresan, A., additional, Kacso, I. M., additional, Song, J.-S., additional, Song, J.-H., additional, Ahn, S.-H., additional, Choi, B. S., additional, Hong, Y. a., additional, Kim, M. Y., additional, Lim, J. H., additional, Yang, K.-S., additional, Chung, S., additional, Shin, S. J., additional, Kim, H. W., additional, Chang, Y. S., additional, Kim, Y. S., additional, Park, C. W., additional, Takayanagi, K., additional, Hasegawa, H., additional, Shimizu, T., additional, Ikari, A., additional, Noiri, C., additional, Iwashita, T., additional, Tayama, Y., additional, Asakura, J., additional, Anzai, N., additional, Kanozawa, K., additional, Kato, H., additional, Mitarai, T., additional, Huang, M., additional, Ashour, R. H., additional, Fouda, A. E.-M. M., additional, Saad, M. A., additional, El-Banna, F. M., additional, Moustafa, F. A., additional, Fouda, M. I., additional, Sanchez-Nino, M. D., additional, Sanz, A. B., additional, Poveda, J., additional, Saleem, M., additional, Mathieson, P., additional, Ruiz-Ortega, M., additional, Selgas, R., additional, Egido, J., additional, Ortiz, A., additional, Soler, M. J., additional, Rebull, M., additional, Marquez, E., additional, Okazaki, S., additional, Kogure, Y., additional, Sano, T., additional, Hatano, M., additional, Kreft, E., additional, Kowalski, R., additional, Szczepansk-Konkel, M., additional, Liu, X., additional, Yang, G., additional, Osman, N. A., additional, NasrAllah, M. M., additional, Kamal, M. M., additional, Ahmed, A. I., additional, Fekih-Mrissa, N., additional, Mrad, M., additional, Baffoun, A., additional, Sayeh, A., additional, Hmida, J., additional, Gritli, N., additional, Galchinskaya, V., additional, Topchii, I., additional, Semenovykh, P., additional, Yefimova, N., additional, Zheng, D., additional, Hu, D., additional, Li, X., additional, Peng, A. I., additional, Olea-Herrero, N., additional, Arenas, M., additional, Munoz-Moreno, C., additional, Moreno-Gomez-Toledano, R., additional, Gonzalez-Santander, M., additional, Arribas, I., additional, and Bosch, R., additional
- Published
- 2013
- Full Text
- View/download PDF
9. Renal physiology and kidney stones
- Author
-
Alexander, R. T., primary, Samuel, S., additional, Wiebe, N., additional, Bello, A., additional, Klarenbach, S., additional, Curhan, G. C., additional, Tonelli, M., additional, Hemmelgarn, B., additional, Mingione, A., additional, Terranegra, A., additional, Aloia, A., additional, Arcidiacono, T., additional, Brasacchio, C., additional, Hou, J., additional, Dell'Antonio, G., additional, Vezzoli, G., additional, Soldati, L., additional, Shimizu, T., additional, Hasegawa, H., additional, Takayanagi, K., additional, Ikari, A., additional, Noiri, C., additional, Iwashita, T., additional, Tayama, Y., additional, Asakura, J., additional, Anzai, N., additional, Sano, T., additional, Ogawa, T., additional, Matsuda, A., additional, and Mitarai, T., additional
- Published
- 2013
- Full Text
- View/download PDF
10. Experimental models of CKD
- Author
-
Kanlaya, R., primary, Sintiprungrat, K., additional, Thongboonkerd, V., additional, Torremade, N., additional, Bindels, R., additional, Hoenderop, J., additional, Fernandez, E., additional, Dusso, A., additional, Valdivielso, J. M., additional, Krueger, T., additional, Boor, P., additional, Schafer, C., additional, Westenfeld, R., additional, Brandenburg, V., additional, Schlieper, G., additional, Jahnen-Dechent, W., additional, Ketteler, M., additional, Jee, W., additional, Li, X., additional, Richards, B., additional, Floege, J., additional, Goncalves, J. G., additional, Canale, D., additional, de Braganca, A. C., additional, Shimizu, M. H. M., additional, Moyses, R. M. A., additional, Andrade, L., additional, Seguro, A. C., additional, Volpini, R. A., additional, Romoli, S., additional, Migliorini, A., additional, Anders, H.-J., additional, Eskova, O., additional, Neprintseva, N., additional, Tchebotareva, N., additional, Bobkova, I., additional, Kozlovskaya, L., additional, Simic, I., additional, Tabatabaeifar, M., additional, Wlodkowski, T., additional, Denc, H., additional, Mollet, G., additional, Antignac, C., additional, Schaefer, F., additional, Ekaterina, I. A., additional, Giardino, L., additional, Rastaldi, M. P., additional, Van den Heuvel, L., additional, Levtchenko, E., additional, Okina, C., additional, Okamoto, T., additional, Kamata, M., additional, Murano, J., additional, Kobayashi, K., additional, Takeuchi, K., additional, Kamata, F., additional, Sakai, T., additional, Naito, S., additional, Aoyama, T., additional, Sano, T., additional, Takeuchi, Y., additional, Kamata, K., additional, Thomasova, D., additional, Bruns, H. A., additional, Liapis, H., additional, Iwashita, T., additional, Hasegawa, H., additional, Takayanagi, K., additional, Shimizu, T., additional, Asakura, J., additional, Okazaki, S., additional, Kogure, Y., additional, Hatano, M., additional, Hara, H., additional, Inamura, M., additional, Iwanaga, M., additional, Mitani, T., additional, Mitarai, T., additional, Savin, V. J., additional, Sharma, M., additional, Wei, C., additional, Reiser, J., additional, McCarthy, E. T., additional, Sharma, R., additional, Gauchat, J.-F., additional, Eneman, B., additional, Freson, K., additional, Van Geet, C., additional, Choi, D. E., additional, Jeong, J. Y., additional, Chang, Y. K., additional, Na, K.-R., additional, Lee, K. W., additional, Shin, Y. T., additional, Ni, H.-F., additional, Chen, J.-F., additional, Zhang, M.-H., additional, Pan, M.-M., additional, Liu, B.-C., additional, Kim, S. S., additional, Suzuki, T., additional, Iyoda, M., additional, Matsumoto, K., additional, Shindo-Hirai, Y., additional, Kuno, Y., additional, Wada, Y., additional, Yamamoto, Y., additional, Shibata, T., additional, Akizawa, T., additional, Munoz-Felix, J. M., additional, Lopez-Novoa, J. M., additional, Martinez-Salgado, C., additional, Ehling, J., additional, Babickova, J., additional, Gremse, F., additional, Kiessling, F., additional, Lammers, T., additional, Lech, M., additional, Gunthner, R., additional, Lorenz, G., additional, Ryu, M., additional, Grobmayr, R., additional, Susanti, H., additional, Kobayashi, K. S., additional, Flavell, R. A., additional, Rayego-Mateos, S., additional, Morgado, J., additional, Sanz, A. B., additional, Eguchi, S., additional, Pato, J., additional, Keri, G., additional, Egido, J., additional, Ortiz, A., additional, Ruiz-Ortega, M., additional, Leduc, M., additional, Geerts, L., additional, Grouix, B., additional, Sarra-Bournet, F., additional, Felton, A., additional, Gervais, L., additional, Abbott, S., additional, Duceppe, J.-S., additional, Zacharie, B., additional, Penney, C., additional, Laurin, P., additional, Gagnon, L., additional, Detsika, M. G., additional, Duann, P., additional, Lianos, E. A., additional, Leong, K. I., additional, Chiang, C.-K., additional, Yang, C.-C., additional, Wu, C.-T., additional, Chen, L.-P., additional, Hung, K.-Y., additional, Liu, S.-H., additional, Carvalho, F. F., additional, Teixeira, V. P., additional, Almeida, W. S., additional, Schor, N., additional, Small, D. M., additional, Bennett, N. C., additional, Coombes, J., additional, Johnson, D. W., additional, Gobe, G. C., additional, Montero, N., additional, Prada, A., additional, Riera, M., additional, Orfila, M., additional, Pascual, J., additional, Rodriguez, E., additional, Barrios, C., additional, Kokeny, G., additional, Fazekas, K., additional, Rosivall, L., additional, Mozes, M. M., additional, Hornigold, N., additional, Hughes, J., additional, Mooney, A., additional, Benardeau, A., additional, Riboulet, W., additional, Vandjour, A., additional, Jacobsen, B., additional, Apfel, C., additional, Conde-Knape, K., additional, Bienvenu, J.-F., additional, Tanaka, T., additional, Yamaguchi, J., additional, Nangaku, M., additional, Niwa, T., additional, Bolati, D., additional, Shimizu, H., additional, Yisireyili, M., additional, Nishijima, F., additional, Brocca, A., additional, Virzi, G., additional, de Cal, M., additional, Ronco, C., additional, Priante, G., additional, Musacchio, E., additional, Valvason, C., additional, Sartori, L., additional, Piccoli, A., additional, Baggio, B., additional, Perkuhn, M., additional, Weibrecht, M., additional, Zok, S., additional, Martin, I. V., additional, Schoth, F., additional, Ostendorf, T., additional, Kuhl, C., additional, Karabaeva, A., additional, Essaian, A., additional, Beresneva, O., additional, Parastaeva, M., additional, Kayukov, I., additional, Smirnov, A., additional, Audzeyenka, I., additional, Kasztan, M., additional, Piwkowska, A., additional, Rogacka, D., additional, Angielski, S., additional, Jankowski, M., additional, Bockmeyer, C. L., additional, Kokowicz, K., additional, Agustian, P. A., additional, Zell, S., additional, Wittig, J., additional, Becker, J. U., additional, Nishizono, R., additional, Venkatareddy, M. P., additional, Chowdhury, M. A., additional, Wang, S. Q., additional, Fukuda, A., additional, Wickman, L. T., additional, Yang, Y., additional, Wiggins, R. C., additional, Fazio, M. R., additional, Donato, V., additional, Lucisano, S., additional, Cernaro, V., additional, Lupica, R., additional, Trimboli, D., additional, Montalto, G., additional, Aloisi, C., additional, Mazzeo, A. T., additional, Buemi, M., additional, Gawrys, O., additional, Olszynski, K. H., additional, Kuczeriszka, M., additional, Gawarecka, K., additional, Swiezewska, E., additional, Chmielewski, M., additional, Masnyk, M., additional, Rafalowska, J., additional, Kompanowska-Jezierska, E., additional, Lee, W.-C., additional, Chau, Y.-Y., additional, Lee, L.-C., additional, Chiu, C.-H., additional, Lee, C.-T., additional, Chen, J.-B., additional, Kim, W.-K., additional, and Shin, S. J., additional
- Published
- 2013
- Full Text
- View/download PDF
11. Diabetes - Basic research
- Author
-
Lopez-Parra, V., primary, Mallavia, B., additional, Oguiza, A., additional, Recio, C., additional, Egido, J., additional, Gomez-Guerrero, C., additional, Ito, M., additional, Nishio, S., additional, Koike, T., additional, Takayanagi, K., additional, Hasegawa, H., additional, Shimizu, T., additional, Asakura, J., additional, Iwashita, T., additional, Tayama, Y., additional, Hara, H., additional, Inamura, M., additional, Kanozawa, K., additional, Kato, H., additional, Mitarai, T., additional, Sanchez-Nino, M. D., additional, Sanchez-Lopez, E., additional, Sanz, A. B., additional, Ruiz-Ortega, M., additional, Saleem, M. A., additional, Mathieson, P. W., additional, Mezzano, S., additional, Ortiz, A., additional, Liu, L., additional, Hu, X., additional, Cai, G.-Y., additional, Lv, Y., additional, Zhuo, L., additional, Gao, J.-J., additional, Cui, S.-Y., additional, Feng, Z., additional, Fu, B., additional, Chen, X.-M., additional, Zaladek Gil, F., additional, Costa, M. C., additional, Hirata, A. E., additional, Camara, N. O., additional, Chen, J.-S., additional, Chang, L.-C., additional, Shieh, Y.-S., additional, Wu, C.-C., additional, Zhang, L., additional, Gu, Y., additional, Lin, S., additional, Buraczynska, M., additional, Zukowski, P., additional, Kuczmaszewska, A., additional, Ksiazek, A., additional, Kimachi, M., additional, Sato, A., additional, Nakagaki, T., additional, Nakazawa, D., additional, Ishikawa, Y., additional, Shibasaki, S., additional, Ahn, E.-M., additional, Choi, J.-Y., additional, Shin, J.-I., additional, Ha, T.-S., additional, Mozul, S., additional, Dragan, M., additional, Lumi, Z., additional, Liu, J., additional, Xiufen, Z., additional, Jun, Q., additional, Changying, X., additional, Zitman-Gal, T., additional, Green, J., additional, Bernheim, J., additional, Benchetrit, S., additional, Watanabe, M., additional, Nakashima, H., additional, Abe, Y., additional, Ito, K., additional, Sato, T., additional, Saito, T., additional, Riera, M., additional, Marquez, E., additional, Rigol, J., additional, Roca, H., additional, Pascual, J., additional, Soler, M. J., additional, Aizawa, K., additional, Hirata, M., additional, Moriguchi, Y., additional, Iehara, N., additional, Terada, M., additional, Matsubara, T., additional, Araki, M., additional, Torikoshi, K., additional, Doi, T., additional, and Fukatsu, A., additional
- Published
- 2011
- Full Text
- View/download PDF
12. ChemInform Abstract: Cerium(IV)-Mediated Halogenation at C-5 of Uracil Derivatives.
- Author
-
ASAKURA, J., primary and ROBINS, M. J., additional
- Published
- 2010
- Full Text
- View/download PDF
13. ChemInform Abstract: Removal of Acetal, Silyl, and 4,4′-Dimethoxytrityl Protecting Groups from Hydroxyl Functions of Carbohydrates and Nucleosides with Clay in Aqueous Methanol.
- Author
-
ASAKURA, J., primary, ROBINS, M. J., additional, ASAKA, Y., additional, and KIM, T. H., additional
- Published
- 2010
- Full Text
- View/download PDF
14. Fault-tolerant control for a battery energy storage system based on a cascade PWM converter
- Author
-
Maharjan, L., primary, Yamagishi, T., additional, Akagi, H., additional, and Asakura, J., additional
- Published
- 2009
- Full Text
- View/download PDF
15. Conformational study of the salivary proline-rich polypeptides
- Author
-
ISEMURA, T., primary, ASAKURA, J., additional, SHIBATA, S., additional, ISEMURA, S., additional, SAITOH, E., additional, and SANADA, K., additional
- Published
- 2009
- Full Text
- View/download PDF
16. Conformational study of the basic proline-rich polypeptides from human parotid saliva
- Author
-
Shibata, S., primary, Asakura, J., additional, Isemura, T., additional, Isemura, S., additional, Saitoh, E., additional, and Sanada, K., additional
- Published
- 2009
- Full Text
- View/download PDF
17. 804 Application of Walking Support System by Suspending from the Ceiling to Rehabilitation
- Author
-
Asakura, J., primary, Zhang, L., additional, Hirano, M., additional, and Sugimoto, N., additional
- Published
- 2005
- Full Text
- View/download PDF
18. Improvement in Gain Margin for a Dual-Rate System.
- Author
-
Sato, T., Asakura, J., Araki, N., and Konishi, Y.
- Published
- 2009
- Full Text
- View/download PDF
19. A transformerless battery energy storage system based on a multilevel cascade PWM converter.
- Author
-
Maharjan, L., Inoue, S., Akagi, H., and Asakura, J.
- Published
- 2008
- Full Text
- View/download PDF
20. ChemInform Abstract: Clay Catalyzed Acetonation: A Simple Method for the Preparation of Isopropylidene Carbohydrates.
- Author
-
ASAKURA, J., primary, MATSUBARA, Y., additional, and YOSHIHARA, M., additional
- Published
- 1996
- Full Text
- View/download PDF
21. ChemInform Abstract: Reaction of Alkylchlorides and Epoxides with Nucleophiles in the Presence of Clay.
- Author
-
TSUJIMOTO, M., primary, MATSUBARA, Y., additional, YOSHIHARA, M., additional, MAESHIMA, T., additional, and ASAKURA, J., additional
- Published
- 1992
- Full Text
- View/download PDF
22. 5′-S-(2-aminoethyl)-N6-(4-nitrobenzyl)-5′-thioadenosine (SAENTA), a novel ligand with high affinity for polypeptides associated with nucleoside transport. Partial purification of the nitrobenzylthioinosine-binding protein of pig erythrocytes by affinity chromatography
- Author
-
Agbanyo, F R, primary, Vijayalakshmi, D, additional, Craik, J D, additional, Gati, W P, additional, McAdam, D P, additional, Asakura, J, additional, Robins, M J, additional, Paterson, A R P, additional, and Cass, C E, additional
- Published
- 1990
- Full Text
- View/download PDF
23. ChemInform Abstract: Reaction of Enones with Iodine in the Presence of Ce(IV) - Synthesis of 2-Iodovinyl Ketones.
- Author
-
KIM, T. H., primary, ASAKURA, J., additional, and ASAKA, Y., additional
- Published
- 1990
- Full Text
- View/download PDF
24. Conformational study of the basic proline-rich polypeptides from human parotid saliva.
- Author
-
Shibata, S., Asakura, J., Isemura, T., Isemura, S., Saitoh, E., and Sanada, K.
- Published
- 1984
- Full Text
- View/download PDF
25. Conformational study of the salivary proline-rich polypeptides.
- Author
-
ISEMURA, T., ASAKURA, J., SHIBATA, S., ISEMURA, S., SAITOH, E., and SANADA, K.
- Published
- 1983
- Full Text
- View/download PDF
26. None
- Author
-
Kano T, Maeda K, and Asakura, J.
- Abstract
None
- Published
- 1975
27. A Parametric Study on the Thermal Stresses of Straight Pipes Under the Typical FBR Thermal Transient Conditions (ERDA-81)
- Author
-
Kano T, Asakura, J., Kano T, and Asakura, J.
- Published
- 1975
28. On the Thermal Stress Analysis of Joyo Code Support Structure
- Author
-
Kano T, Maeda K, Asakura, J., Kano T, Maeda K, and Asakura, J.
- Published
- 1975
29. ChemInform Abstract: Cerium(IV) Catalyzed Iodination at C5 of Uracil Nucleosides (I).
- Author
-
ASAKURA, J., primary and ROBINS, M. J., additional
- Published
- 1988
- Full Text
- View/download PDF
30. Application of IEC61131-3 for semiconductor processing equipment
- Author
-
Sato, T., primary, Yoshida, E., additional, Kakebayashi, Y., additional, Asakura, J., additional, and Komoda, N., additional
- Full Text
- View/download PDF
31. Application of IEC61131-3 for semiconductor processing equipment.
- Author
-
Sato, T., Yoshida, E., Kakebayashi, Y., Asakura, J., and Komoda, N.
- Published
- 2001
- Full Text
- View/download PDF
32. ChemInform Abstract: Removal of Acetal, Silyl, and 4,4′-Dimethoxytrityl Protecting Groups from Hydroxyl Functions of Carbohydrates and Nucleosides with Clay in Aqueous Methanol.
- Author
-
ASAKURA, J., ROBINS, M. J., ASAKA, Y., and KIM, T. H.
- Published
- 1997
- Full Text
- View/download PDF
33. ChemInform Abstract: Cerium(IV)-Mediated Halogenation at C-5 of Uracil Derivatives.
- Author
-
ASAKURA, J. and ROBINS, M. J.
- Published
- 1991
- Full Text
- View/download PDF
34. Assessment of transthyretin instability in patients with wild-type transthyretin amyloid cardiomyopathy.
- Author
-
Iino T, Nagao M, Tanaka H, Yoshikawa S, Asakura J, Nishimori M, Shinohara M, Harada A, Watanabe S, Ishida T, Hirata KI, and Toh R
- Subjects
- Humans, Male, Female, Aged, Middle Aged, Protein Stability, Mutation, Kinetics, Prealbumin genetics, Prealbumin metabolism, Amyloid Neuropathies, Familial genetics, Amyloid Neuropathies, Familial metabolism, Cardiomyopathies genetics, Cardiomyopathies metabolism
- Abstract
The pathophysiology of variant transthyretin (TTR) amyloidosis (ATTRv) is associated with destabilizing mutations in the TTR tetramer. However, why TTR with a wild-type genetic sequence misfolds and aggregates in wild-type transthyretin amyloidosis (ATTRwt) is unknown. Here, we evaluate kinetic TTR stability with a newly developed ELISA system in combination with urea-induced protein denaturation. Compared with that in control patients, endogenous TTR in patients with wild-type transthyretin amyloid cardiomyopathy (ATTRwt-CM) exhibited thermodynamic instability, indicating that circulating TTR instability may be associated with the pathogenesis of ATTRwt as well as ATTRv. Our findings provide new insight into the underlying mechanisms of ATTRwt., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
35. Impaired Cholesterol Uptake Capacity in Patients with Hypertriglyceridemia and Diabetes Mellitus.
- Author
-
Seto Y, Nagao M, Iino T, Harada A, Murakami K, Miwa K, Shinohara M, Nishimori M, Yoshikawa S, Asakura J, Fujioka T, Ishida T, Hirata KI, and Toh R
- Subjects
- Humans, Male, Female, Middle Aged, Aged, Diabetes Mellitus blood, Diabetes Mellitus diagnosis, Apolipoprotein A-I blood, Cholesterol blood, Glycated Hemoglobin metabolism, Glycated Hemoglobin analysis, Hypertriglyceridemia blood, Hypertriglyceridemia diagnosis, Hypertriglyceridemia complications, Hypertriglyceridemia etiology, Insulin Resistance, Cholesterol, HDL blood, Triglycerides blood
- Abstract
Background: Although low high-density lipoprotein cholesterol (HDL-C) levels are a common metabolic abnormality associated with insulin resistance, their role in cardiovascular risk stratification remains controversial. Recently, we developed a simple, high-throughput, cell-free assay system to evaluate the "cholesterol uptake capacity (CUC)" as a novel concept for HDL functionality. In this study, we assessed the CUC in patients with hypertriglyceridemia and diabetes mellitus., Methods: The CUC was measured using cryopreserved serum samples from 285 patients who underwent coronary angiography or percutaneous coronary intervention between December 2014 and May 2019 at Kobe University Hospital., Results: The CUC was significantly lower in diabetic patients (n = 125) than in nondiabetic patients (93.0 vs 100.7 arbitrary units (A.U.), P = 0.002). Patients with serum triglyceride (TG) levels >150 mg/dL (n = 94) also had a significantly lower CUC (91.8 vs 100.0 A.U., P = 0.004). Furthermore, the CUC showed a significant inverse correlation with TG, hemoglobin A1c (Hb A1c), homeostasis model assessment of insulin resistance (HOMA-IR), and body mass index (BMI). Finally, the HDL-C/Apolipoprotein A1 (ApoA1) ratio, calculated as a surrogate index of HDL particle size, was significantly positively correlated with the CUC (r2 = 0.49, P < 0.001), but inversely correlated with TG levels (r2 = -0.30, P < 0.001)., Conclusions: The CUC decreased in patients with hypertriglyceridemia and diabetes mellitus, and HDL particle size was a factor defining the CUC and inversely correlated with TG levels, suggesting that impaired CUC in insulin-resistant states was partially due to the shift in HDL towards smaller particles. These findings provide a better understanding of the mechanisms underlying impaired HDL functionality., (Published by Oxford University Press on behalf of Association for Diagnostics & Laboratory Medicine 2024.)
- Published
- 2024
- Full Text
- View/download PDF
36. Hypercalcemic Crisis Due to Parathyroid Adenoma Improved by Continuous Hemodialysis with a Common Calcium Concentration Dialysate: Discussion of Therapeutic Management.
- Author
-
Okuyama H, Sato R, Enomoto K, Asakura J, and Hatakeyama T
- Subjects
- Male, Humans, Aged, Calcium, Dialysis Solutions, Calcium, Dietary, Renal Dialysis, Hypercalcemia etiology, Hypercalcemia therapy, Parathyroid Neoplasms complications, Parathyroid Neoplasms surgery, Hyperparathyroidism, Primary complications, Hyperparathyroidism, Primary therapy
- Abstract
A hypercalcemic crisis due to primary hyperparathyroidism is a life-threatening condition. We herein report a 71-years-old man with hypercalcemic crisis due to primary hyperparathyroidism with parathyroid adenoma. Generally, hemodialysis or continuous hemodiafiltration using calcium-free or low-calcium dialysate is performed early for hypercalcemic crisis. In this case, continuous hemodialysis with a common calcium concentration dialysate improved the hypercalcemic crisis, and parathyroidectomy was performed. The patient recovered sufficiently. Prediction of hypercalcemia crisis, appropriate introduction and methods of blood purification therapy, and timing decisions for parathyroidectomy are required for therapeutic management of hypercalcemic crisis with parathyroid adenoma.
- Published
- 2024
- Full Text
- View/download PDF
37. Stress-induced stenotic vascular remodeling via reduction of plasma omega-3 fatty acid metabolite 4-oxoDHA by noradrenaline.
- Author
-
Nishimori M, Hayasaka N, Otsui K, Inoue N, Asakura J, Nagao M, Toh R, Ishida T, Hirata KI, Furuyashiki T, and Shinohara M
- Subjects
- Humans, Mice, Animals, Endothelial Cells metabolism, Norepinephrine, Vascular Remodeling, Inflammation drug therapy, Fatty Acids, Omega-3 metabolism
- Abstract
Stress has garnered significant attention as a prominent risk factor for inflammation-related diseases, particularly cardiovascular diseases (CVDs). However, the precise mechanisms underlying stress-driven CVDs remain elusive, thereby impeding the development of preventive and therapeutic strategies. To explore the correlation between plasma lipid metabolites and human depressive states, liquid chromatography-mass spectrometry (LC/MS) based analysis of plasma and the self-rating depression (SDS) scale questionnaire were employed. We also used a mouse model with restraint stress to study its effects on plasma lipid metabolites and stenotic vascular remodeling following carotid ligation. In vitro functional and mechanistic studies were performed using macrophages, endothelial cells, and neutrophil cells. We revealed a significant association between depressive state and reduced plasma levels of 4-oxoDHA, a specific omega-3 fatty acid metabolite biosynthesized by 5-lipoxygenase (LO), mainly in neutrophils. In mice, restraint stress decreased plasma 4-oxoDHA levels and exacerbated stenotic vascular remodeling, ameliorated by 4-oxoDHA supplementation. 4-oxoDHA enhanced Nrf2-HO-1 pathways, exerting anti-inflammatory effects on endothelial cells and macrophages. One of the stress hormones, noradrenaline, reduced 4-oxoDHA and the degraded 5-LO in neutrophils through the proteasome system, facilitated by dopamine D2-like receptor activation. Our study proposed circulating 4-oxoDHA levels as a stress biomarker and supplementation of 4-oxoDHA as a novel therapeutic approach for controlling stress-related vascular inflammation., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
38. Plasma cystine/methionine ratio is associated with left ventricular diastolic function in patients with heart disease.
- Author
-
Asakura J, Nagao M, Shinohara M, Nishimori M, Yoshikawa S, Iino T, Seto Y, Tanaka H, Satomi-Kobayashi S, Ishida T, Hirata KI, and Toh R
- Subjects
- Humans, Methionine, Chromatography, Liquid, Tandem Mass Spectrometry, Ventricular Function, Left, Stroke Volume, Diastole, Cystine, Ventricular Dysfunction, Left diagnosis, Ventricular Dysfunction, Left etiology
- Abstract
Elevated circulating homocysteine (Hcy) is a well-known risk factor for cardiovascular diseases (CVDs), including coronary artery disease (CAD) and heart failure (HF). It remains unclear how Hcy and its derivatives relate to left ventricular (LV) diastolic function. The aim of the present study was to investigate the relationship between plasma Hcy-related metabolites and diastolic dysfunction (DD) in patients with heart disease (HD). A total of 62 HD patients with preserved LV ejection fraction (LVEF ≥ 50%) were enrolled. Plasma Hcy and its derivatives were measured by liquid chromatography‒mass spectrometry (LC-MS/MS). Spearman's correlation test and multiple linear regression models were used to analyze the associations between metabolite levels and LV diastolic function. The cystine/methionine (CySS/Met) ratio was positively correlated with LV diastolic function, which was defined from the ratio of mitral inflow E and mitral e' annular velocities (E/e') (Spearman's r = 0.43, p < 0.001). When the subjects were categorized into two groups by E/e', the high-E/e' group had a significantly higher CySS/Met ratio than the low-E/e' group (p = 0.002). Multiple linear regression models revealed that the CySS/Met ratio was independently associated with E/e' after adjustment for age, sex, body mass index (BMI), diabetes mellitus, hypertension, chronic kidney disease (CKD), hemoglobin, and lipid peroxide (LPO) {standardized β (95% CI); 0.14 (0.04-0.23); p = 0.005}. Hcy, CySS, and Met did not show a significant association with E/e' in the same models. A high plasma CySS/Met ratio reflected DD in patients with HD., (© 2023. Springer Nature Japan KK, part of Springer Nature.)
- Published
- 2023
- Full Text
- View/download PDF
39. Pediatric multisystem SARS COV2 with versus without cardiac involvement: a multicenter study from Latin America.
- Author
-
Pignatelli R, Antona CV, Rivera IR, Zenteno PA, Acosta YT, Huertas-Quiñones M, Murillo CA, Torres FM, Cabalin CF, Camacho AG, Pérez AA, Lombardi AB, Soares AM, Garcia CT, Borges CT, Villalba CN, Lechado CR, Dias DT, Morales DA, Copete EM, Goldenberg GL, Salazar JS, Moreira JA, Asakura J, Sabando KS, Branco KC, Rosas LT, Duarte MP, Carbajal MJ, Hernandez MR, Martínez MM, Echeverría NG, Caneva OM, Sepulveda PR, Díaz PA, Plúas RR, Alvarado TC, Faundes LT, Diaz YB, and Zachariah JP
- Subjects
- Adolescent, Arrhythmias, Cardiac, Child, Child, Preschool, Critical Care, Female, Humans, Infant, Infant, Newborn, Latin America epidemiology, Male, COVID-19, SARS-CoV-2
- Abstract
Latin America (LATAM) children offer special insight into Severe Acute Respiratory Syndrome Coronavirus 2 (SARS COV2) due to high-risk race/ethnicity, variability in medical resources, diverse socioeconomic background, and numerous involved organ systems. This multinational study of LATAM youth examined the distinguishing features of acute or late multisystem SARS COV2 with versus without cardiac involvement. A consecutive sample of youth 0-18 years old (N = 98;50% male) presenting with multisystem SARS COV2 to 32 centers in 10 Latin American countries participating in a pediatric cardiac multi-imaging society were grouped as with versus without cardiac involvement, defined as abnormal echocardiographic findings or arrhythmia. Collected clinical data were analyzed by Student's t-test or Fisher's exact test. Cardiac (N = 48, 50% male) versus no cardiac (N = 50, 50% male) were similar in age; weight; nonrespiratory symptoms; and medical history. The cardiac group had 1 death and symptoms including coronary artery dilation, ejection fraction <50%, pericardial effusion, peripheral edema, arrhythmia, and pulmonary artery thrombus. The cardiac group had higher risk of ICU admission (77% vs 54%, p = 0.02); invasive ventilation (23% vs 4%,p = 0.007); vasoactive infusions (27% vs 4%, p = 0.002); prominent respiratory symptoms (60% vs 36%, p < 0.03); abnormal chest imaging (69% vs 34%, p = 0.001); troponin (33% vs 12%, p = 0.01); alanine aminotransferase (33% vs 12%, p = 0.02); and thrombocytopenia (46% vs 22%, p = 0.02). Receiver operating curve analysis showed that abnormal laboratories had 94% sensitivity and 98% negative predictive value on the need for ICU interventions.Conclusion: In LATAM children with multisystem SARS COV2, cardiac involvement was prevalent. Cardiac involvement was more likely to require ICU interventions, certain abnormal labs, and respiratory involvement. What is Known: • SARS COV2 can be asymptomatic in children but in some cases can have serious multisystemic involvement. • Hispanic ethnicity is purportedly at high risk of SARS COV2 in nations where they are often disadvantaged minority populations. What is New: • Latin American children presenting with multisystem SARS COV2 frequently have cardiac involvement which was associated with ICU interventions; prominent respiratory symptoms; abnormal chest X-ray; elevated troponin, ALT, and thrombocytopenia. • Elevated troponin, ALT or thrombocytopenia had high sensitivity and negative predictive value on the need for intensive care interventions., (© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.)
- Published
- 2021
- Full Text
- View/download PDF
40. Downregulation of transient receptor potential M6 channels as a cause of hypermagnesiuric hypomagnesemia in obese type 2 diabetic rats.
- Author
-
Takayanagi K, Shimizu T, Tayama Y, Ikari A, Anzai N, Iwashita T, Asakura J, Hayashi K, Mitarai T, and Hasegawa H
- Subjects
- Animals, Blood Glucose metabolism, Down-Regulation physiology, Insulin Resistance physiology, Male, Rats, Inbred OLETF, Diabetes Mellitus, Experimental metabolism, Diabetes Mellitus, Type 2 metabolism, Diabetic Nephropathies metabolism, Obesity metabolism, Renal Tubular Transport, Inborn Errors metabolism, TRPM Cation Channels metabolism
- Abstract
We assessed the expression profile of Mg(2+)-transporting molecules in obese diabetic rats as a cause of hypermagnesiuric hypomagnesemia, which is involved in the development of insulin resistance, hypertension, and coronary diseases. Kidneys were obtained from male Otsuka Long-Evans Tokushima fatty (OLETF) and Long-Evans Tokushima Otsuka (LETO) obese diabetic rats at the ages of 16, 24, and 34 wk. Expression profiles were studied by real-time PCR and immunohistochemistry together with measurements of urine Mg(2+) excretion. Urine Mg(2+) excretion was increased in 24-wk-old OLETF rats and hypomagnesemia was apparent in 34-wk-old OLETF rats but not in LETO rats (urine Mg(2+) excretion: 0.16 ± 0.01 μg·min(-1)·g body wt(-1) in 24-wk-old LETO rats and 0.28 ± 0.01 μg·min(-1)·g body wt(-1) in 24-wk-old OLETF rats). Gene expression of transient receptor potential (TRP)M6 was downregulated (85.5 ± 5.6% in 34-wk-old LETO rats and 63.0 ± 3.5% in 34-wk-old OLETF rats) concomitant with Na(+)-Cl(-) cotransporter downregulation, whereas the expression of claudin-16 in tight junctions of the thick ascending limb of Henle was not different. The results of the semiquantitative analysis of immunohistochemistry were consistent with these findings (TRPM6: 0.49 ± 0.04% in 16-wk-old LETO rats, 0.10 ± 0.01% in 16-wk-old OLETF rats, 0.52 ± 0.03% in 24-wk-old LETO rats, 0.10 ± 0.01% in 24-wk-old OLETF rats, 0.48 ± 0.02% in 34-wk-old LETO rats, and 0.12 ± 0.02% in 34-wk-old OLETF rats). Gene expression of fibrosis-related proinflammatory cytokines as well as histological changes showed that the hypermagnesiuria-related molecular changes and tubulointerstitial nephropathy developed independently. TRPM6, located principally in distal convoluted tubules, appears to be a susceptible molecule that causes hypermagnesiuric hypomagnesemia as a tubulointerstitial nephropathy-independent altered tubular function in diabetic nephropathy., (Copyright © 2015 the American Physiological Society.)
- Published
- 2015
- Full Text
- View/download PDF
41. Prevention of lipopolysaccharide-induced peritoneal damage by eplerenone in rats undergoing peritoneal dialysis.
- Author
-
Tayama Y, Hasegawa H, Takayanagi K, Matsuda A, Shimizu T, Asakura J, Iwashita T, Ogawa T, Katoh H, and Mitarai T
- Subjects
- Animals, Chemokine CCL2 metabolism, Creatinine, Eplerenone, Lipopolysaccharides, Male, Osmosis drug effects, Peritoneal Dialysis, Peritoneal Diseases microbiology, Peritoneum drug effects, Peritoneum pathology, Peritonitis drug therapy, Peritonitis etiology, Random Allocation, Rats, Rats, Sprague-Dawley, Spironolactone therapeutic use, Transforming Growth Factor beta1 metabolism, Ultrafiltration, von Willebrand Factor metabolism, Dialysis Solutions adverse effects, Mineralocorticoid Receptor Antagonists therapeutic use, Peritoneal Diseases prevention & control, Spironolactone analogs & derivatives
- Abstract
Background: Bacterial peritonitis in patients undergoing peritoneal dialysis (PD) is a major cause of therapy interruption due to peritoneal insufficiency. Here we studied the effect of a selective mineralocorticoid receptor (MR) blocker, eplerenone, on the prevention of peritoneal damage. , Methods: Male Sprague-Dawley rats were treated with a daily infusion of human use PD solution (100 mL/kg i.p., PD group, n = 5), or with PD solution and intermittent intraperitoneal injections of lipopolysaccharide (LPS group, n = 5) or with LPS and eplerenone (100 mg/ kg/d, po, Ep group, n = 5) for 4 weeks. Peritoneal samples were subjected to assessment following the peritoneal equilibration test (PET)., Results: Histological observations revealed that LPS treatment resulted in significant peritoneal thickening associated with increased ED-1-positive cell infiltration and the number of transforming growth factor (TGF)-β1-positive cells, and that eplerenone reduced these changes. LPS administration also evoked significant upregulation of monocyte chemotactic protein-1 and TGF-β1, which were inhibited by eplerenone. PET revealed that ultrafiltration and transperitoneal osmotic diffusion were significantly impaired by LPS and restored by eplerenone. Increased value of the mass transfer area coefficients for creatinine values was also recovered by Ep (0.10 ± 0.01 in the PD, 0.14 ± 0.02 in the LPS and 0.08 ± 0.0 in the Ep groups). Immunostaining for von Willebrand factor showed a significant increase by LPS and its restoration by Ep. , Conclusions: Ep effectively diminished LPS-induced peritoneal insufficiency. A selective blockade of MR might prevent peritoneal insufficiency associated with bacterial peritonitis.
- Published
- 2013
- Full Text
- View/download PDF
42. Significance of estimated salt excretion as a possible predictor of the efficacy of concomitant angiotensin receptor blocker (ARB) and low-dose thiazide in patients with ARB resistance.
- Author
-
Hasegawa H, Kanozawa K, Asakura J, Takayanagi K, Komuro O, Fukada H, Tokushima H, Kogure H, Matsuzawa M, and Mitarai T
- Subjects
- Aged, Aged, 80 and over, Angiotensin II Type 1 Receptor Blockers pharmacology, Angiotensin II Type 1 Receptor Blockers therapeutic use, Antihypertensive Agents pharmacology, Blood Pressure drug effects, Drug Therapy, Combination, Female, Humans, Hydrochlorothiazide pharmacology, Losartan pharmacology, Male, Middle Aged, Sodium Chloride Symporter Inhibitors pharmacology, Sodium Chloride Symporter Inhibitors therapeutic use, Treatment Outcome, Antihypertensive Agents therapeutic use, Hydrochlorothiazide therapeutic use, Hypertension drug therapy, Hypertension metabolism, Losartan therapeutic use, Sodium Chloride metabolism
- Abstract
The purpose of this study was to assess the factors affecting the efficacy of combination therapy with losartan and thiazide, with a focus on the significance of salt excretion, via a multicenter observational study. Adult patients with essential hypertension showing therapy resistance to angiotensin receptor blocker (ARB) as a monotherapy or in combination with Ca channel blockers (CCB) were enrolled, and their previously administered ARBs were replaced with the combination tablet containing losartan (50 mg per day) and hydrochlorothiazide (12.5 mg per day). Blood pressure and biochemical parameters were monitored for a year. The baseline blood pressure (153.4±14.8/86.4±11.3 mm Hg) was significantly lowered at the 3rd month (137.3±17.4/78.2±11.1 mm Hg, n=93) and was maintained at this lower level until the 12th month (135.3±14.0/76.4±11.1 mm Hg, n=74). The baseline value of estimated salt excretion (eSE), calculated using Tanaka's formula, differed significantly between the high and low treatment response groups, which were defined by the average change in mean blood pressure (MBP-C, -11.3 mm Hg; eSE=10.8±2.9 g per day in high responders vs. 9.2±2.3 g per day in low responders, P=0.004). Univariate and multivariate analyses showed a significant correlation between eSE and MBP-C (R=-0.288, P=0.007) and indicated the clinical effectiveness of eSE as a possible predictor for MBP-C (P=0.021). In addition, the urine Na-to-Cr ratio (NCR) demonstrated significant correlations with eSE (R=0.848, P<0.001) and MBP-C (R=-0.344, P<0.001). These results suggest that eSE or NCR could, to a certain extent, predict the efficacy of combination therapy with losartan and low-dose thiazide in patients demonstrating ARB resistance. Combination therapy with losartan and thiazide might thus be suitable for patients with a large amount of salt excretion.
- Published
- 2013
- Full Text
- View/download PDF
43. Release from glomerular overload by the addition of low-dose thiazide in patients with angiotensin receptor blocker-resistant hypertension.
- Author
-
Hasegawa H, Tayama Y, Takayanagi K, Asakura J, Nakamura T, Kawashima K, Shimizu T, Iwashita T, Ogawa T, Matsuda A, and Mitarai T
- Subjects
- Aged, Aged, 80 and over, Albuminuria drug therapy, Albuminuria metabolism, Albuminuria physiopathology, Dose-Response Relationship, Drug, Drug Combinations, Essential Hypertension, Female, Humans, Hypertension metabolism, Kidney Glomerulus drug effects, Kidney Glomerulus physiopathology, Male, Middle Aged, Prospective Studies, Angiotensin II Type 1 Receptor Blockers administration & dosage, Glomerular Filtration Rate drug effects, Glomerular Filtration Rate physiology, Hydrochlorothiazide administration & dosage, Hypertension drug therapy, Hypertension physiopathology, Losartan administration & dosage
- Abstract
Background/aims: This multicenter, prospective, observational study assessed the renoprotective effects of losartan/thiazide combination therapy in terms of lowering the estimated glomerular filtration rate (eGFR)., Methods: Adult patients with angiotensin receptor blocker (ARB)-resistant essential hypertension (n = 104) were enrolled and switched to combination therapy with losartan (50 mg/day) and hydrochlorothiazide (12.5 mg/day)., Results: eGFR values declined significantly during the first 3 months, and changes in eGFR were assessed according to tertiles of the eGFR decrease ratio at 3 months. Only the high eGFR decrease (1st tertile) group showed significantly greater decreases in baseline eGFR and albumin-to-creatinine ratio (ACR) during the first 3 months. Additionally, the assessment according to tertiles of the baseline eGFR showed a signifcant decrease in eGFR and ACR during the first 3 months in the high baseline eGFR (1st tertile) group, but not in the moderate (2nd tertile) and low baseline eGFR (3rd tertile) groups., Conclusion: The present results revealed that losartan/thiazide combination therapy attenuated glomerular overload, indicating that this therapy may provide glomerular protection in patients with an elevated GFR without causing prolonged damage to renal function., (© 2013 S. Karger AG, Basel.)
- Published
- 2013
- Full Text
- View/download PDF
44. Renoprotective effect of pioglitazone by the prevention of glomerular hyperfiltration through the possible restoration of altered macula densa signaling in rats with type 2 diabetic nephropathy.
- Author
-
Asakura J, Hasegawa H, Takayanagi K, Shimazu T, Suge R, Shimizu T, Iwashita T, Tayama Y, Matsuda A, Kanozawa K, Araki N, and Mitarai T
- Subjects
- Animals, Cyclooxygenase 2 metabolism, Desmin biosynthesis, Diabetic Nephropathies prevention & control, Juxtaglomerular Apparatus drug effects, Male, Nitric Oxide Synthase Type I metabolism, Pioglitazone, Rats, Rats, Inbred OLETF, Signal Transduction, Thiazolidinediones pharmacology, Transforming Growth Factor beta biosynthesis, Diabetic Nephropathies drug therapy, Juxtaglomerular Apparatus physiology, Kidney Glomerulus drug effects, Thiazolidinediones therapeutic use
- Abstract
Background/aims: Pioglitazone (PGZ), one of the thiazolidinediones, has been known to show renoprotective effects. In this study, we focused on the effect of PGZ on glomerular hyperfiltration (GHF), resultant glomerular injury and altered macula densa signaling as a cause of sustained GHF through modified tubuloglomerular feedback in rats with diabetic nephropathy., Methods: Kidneys from 24-week-old male OLETF rats and LET rats, nondiabetic controls, were used for the experiment. PGZ was administered (10 mg/kg/day, p.o.) for 2 weeks from 22 to 24 weeks of age in some of the OLETF rats (OLETF+PGZ)., Results: Parameters relating GHF, kidney weight, creatinine clearance, urine albumin/creatinine ratio and glomerular surface were all increased in OLETF rats and partially restored in OLETF+PGZ rats. Expressions of desmin and TGF-β were also increased in OLETF rats and restored in OLETF+PGZ rats. The changes in TGF-β expression were confirmed to be independent of podocyte number. Finally, the immunoreactivity of neuronal nitric oxide synthase (nNOS) and cyclooxygenase 2 (COX-2) in the macula densa was assessed for the evaluation of macula densa signaling. Altered intensities of nNOS and COX-2 in OLETF rats were restored in OLETF+PGZ rats, which agreed with the gene expression analysis (nNOS: 100.2 ± 2.9% in LET, 64.2 ± 2.7% in OLETF, 87.4 ± 12.1% in OLETF+PGZ; COX-2: 100.8 ± 7.4% in LET, 249.2 ± 19.4% in OLETF, 179.9 ± 13.5% in OLETF+PGZ; n = 5) and the semiquantitative analysis of nNOS/COX-2-positive cells., Conclusion: PGZ effectively attenuated the GHF and hyperfiltration-associated glomerular injury in diabetic nephropathy. The restoration of altered macula densa signaling might be involved in the renoprotective effect of PGZ., (2013 S. Karger AG, Basel)
- Published
- 2012
- Full Text
- View/download PDF
45. [Three-dimensional dynamic MR imaging with a volumetric interpolated breath-hold examination for solitary pulmonary lesions: correlation of contrast enhancement pattern with pathological features].
- Author
-
Tozaki M, Suzuki M, Takeda H, Tai H, Asakura J, Miyoshi I, Katou H, Fukunaga M, Naruo K, and Fukuda Y
- Subjects
- Adenocarcinoma diagnosis, Adenocarcinoma pathology, Adult, Aged, Carcinoma, Squamous Cell diagnosis, Carcinoma, Squamous Cell pathology, Echo-Planar Imaging, Feasibility Studies, Female, Humans, Male, Middle Aged, Tuberculoma diagnosis, Tuberculoma pathology, Imaging, Three-Dimensional, Lung Neoplasms diagnosis, Lung Neoplasms pathology, Magnetic Resonance Imaging methods
- Abstract
Purpose: To evaluate the clinical feasibility of dynamic MR imaging of solitary pulmonary lesions (SPLs) using a fat-suppressed three-dimensional gradient-echo technique with a volumetric interpolated breath-hold examination (VIBE). Correlation between the enhancement pattern and the histological characteristics of the nodules was also assessed., Materials and Methods: Dynamic 3D-VIBE was performed in 16 patients with pathologically proven SPLs. Each lesion was analyzed for its internal enhancement pattern, dynamic enhancement pattern, and peripheral enhancement (PE)., Results: A heterogeneous pattern of internal enhancement was well correlated with histological observation of necrosis, cystic changes, and variously sized air spaces. The washout pattern was seen in the medullary parts of the nodules with little fibrous stroma. The progressive pattern was seen at foci of collapse in the alveolar structure, central scars, and prominent fibrosis. PE was also seen in 6 malignant lesions (43%), and was well correlated with the medullary growth of adenocarcinoma and marginal fibrosis with lymphocytic infiltration of squamous cell carcinoma. The presence of PE was statistically significantly related with tumor size (p < 0.05)., Conclusion: Dynamic 3D-VIBE allows assessment of the histological characteristics of SPLs. It is also thought that this technique may be a promising method for differentiation between benign and malignant lesions.
- Published
- 2004
46. [Study on surgical treatment for lung cancer associated with giant bullous disease].
- Author
-
Sato S, Asakura J, Suzuki H, Hirano J, Ohmori H, Takahisa K, Miyoshi I, Masubuchi M, Akiba T, and Yamazaki Y
- Subjects
- Adenocarcinoma complications, Adult, Carcinoma, Non-Small-Cell Lung complications, Humans, Lung Diseases complications, Lung Neoplasms complications, Male, Middle Aged, Adenocarcinoma surgery, Blister complications, Carcinoma, Non-Small-Cell Lung surgery, Lung Neoplasms surgery
- Abstract
Five patients of primary lung cancer with giant bullous disease underwent surgery from April 1985 to December 1995. All patients were male and heavy smokers, and the median age was 50 years. The location of the tumor was in the right upper lobe in four patients and in the left upper lobe in the other. Three patients were treated by lobectomy and two by sleeve lobectomy. Histological examination showed large cell carcinoma in four patients and poorly-differentiated adenocarcinoma in the other. The pathological stage was I in three. IIIA in one, and IV in the other. Two of three in stage I have survived for more than 6 years postopertively without recurrence, and the other died of brain metastasis. The stage IIIA case and the IV case died 3 years and one year postoperatively, respectively. The clinical features of lung cancer associated with giant bullous disease was discussed by reviewing 33 patients reported in Japan, including our patients. In 13 patients, lung cancer and bullous disease were diagnosed simultaneously (group A), and in 20 patients, bullous disease were diagnosed prior to the appearance of an abnormal shadow due to lung cancer (group B). The patients in group B had a tendency to be diagnosed at an earlier stage of lung cancer than the patients in group A. In the patients of stage I, the 5-year survival rate was 78.6%, however, in the patients of more than stage IIIA, 3-year survival rate was 26.5% and the 5-year survival rate was 0%. Significant differences in the survival curves were demonstrated between the cases with stage I and the cases with more than stage IIIA. In conclusion, in order to improve the prognosis of lung cancer with giant bullous disease, it is considered to be important to detect giant bulla prior to lung cancer, and when a case of bullous disease is found, periodical follow-up must be done to find early stage lung cancer.
- Published
- 1998
- Full Text
- View/download PDF
47. Retarding effect of dodecyl alcohol on polyacrylamide gel electrophoresis of SDS micelles and SDS-protein polypeptide complexes.
- Author
-
Takagi T, Kubo K, Asakura J, and Isemura T
- Subjects
- Binding Sites, Electrophoresis, Polyacrylamide Gel methods, Molecular Weight, Protein Binding, Alcohols, Colloids, Micelles, Proteins, Sodium Dodecyl Sulfate
- Abstract
Micelles of sodium dodecyl sulfate (SDS) are significantly retarded by the addition of a small amount of dodecyl alcohol to a sample solution in SDS-polyacrylamide gel electrophoresis. The phenomenon can be ascribed to the decrease in charge density due to the incorporation of dodecyl alcohol into SDS micelles. The effect is extended to SDS-protein polypeptide complexes when the amount of SDS micelles is insufficient to accomodate the dodecyl alcohol. A similar effect is likely to occur when SDS-polyacrylamide gel electrophoresis is applied to a sample containing lipophilic materials.
- Published
- 1975
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.